Crop Life Science Inkomsten in het verleden
Verleden criteriumcontroles 3/6
Crop Life Science has been growing earnings at an average annual rate of 17.5%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been growing at an average rate of 17.5% per year. Crop Life Science's return on equity is 8.4%, and it has net margins of 3%.
Belangrijke informatie
17.5%
Groei van de winst
14.0%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 17.7% |
| Inkomstengroei | 17.5% |
| Rendement op eigen vermogen | 8.4% |
| Nettomarge | 3.0% |
| Laatste winstupdate | 31 Mar 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Crop Life Science geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 24 | 1,986 | 60 | 113 | 0 |
| 31 Dec 23 | 1,739 | 63 | 112 | 0 |
| 30 Sep 23 | 1,492 | 65 | 111 | 0 |
| 30 Jun 23 | 1,402 | 53 | 112 | 0 |
| 31 Mar 23 | 1,312 | 41 | 113 | 0 |
| 28 Feb 23 | 1,337 | 48 | 129 | 0 |
| 31 Mar 22 | 1,020 | 28 | 136 | 0 |
| 31 Mar 21 | 1,189 | 37 | 139 | 0 |
| 31 Mar 20 | 1,351 | 32 | 121 | 0 |
Kwaliteitswinsten: CLSL has a high level of non-cash earnings.
Groeiende winstmarge: CLSL's current net profit margins (3%) are lower than last year (3.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: CLSL's earnings have grown by 17.5% per year over the past 5 years.
Versnelling van de groei: CLSL's earnings growth over the past year (48.4%) exceeds its 5-year average (17.5% per year).
Winst versus industrie: CLSL earnings growth over the past year (48.4%) exceeded the Chemicals industry 10.4%.
Rendement op eigen vermogen
Hoge ROE: CLSL's Return on Equity (8.4%) is considered low.